Dipeptide Inhibitors as Potent Botulinum Neurotoxin Type A Light Chain Inhibitors

被引：0
|
作者：
Amezcua, Martin [1 ]
Cruz, Ricardo S. [1 ]
Ku, Alex [1 ]
Moran, Wilfred [1 ]
Ortega, Marcos E. [2 ]
Salzameda, Nicholas T. [1 ]
机构：
[1] Calif State Univ Fullerton, Dept Chem & Biochem, Fullerton, CA 92634 USA
[2] Texas Tech Univ, Woody L Hunt Sch Dent Med, El Paso, TX USA
来源：
TOXICON | 2022年 / 214卷
关键词：
Botulinum neurotoxin light chain; Drug discovery; Enzyme assay; Peptides; Small molecule inhibitors; X-ray crystallography;
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：S4 / S4
页数：1
相关论文
共 50 条
  • [1] Discovery of Dipeptides as Potent Botulinum Neurotoxin A Light-Chain Inhibitors
    Amezcua, Martin
    Cruz, Ricardo S.
    Ku, Alex
    Moran, Wilfred
    Ortega, Marcos E.
    Salzameda, Nicholas T.
    ACS MEDICINAL CHEMISTRY LETTERS, 2021, 12 (02): : 295 - 301
  • [2] Development of potent inhibitors of botulinum neurotoxin type B
    Anne, C
    Turcaud, S
    Quancard, J
    Teffo, F
    Meudal, H
    Fournié-Zaluski, MC
    Roques, BP
    JOURNAL OF MEDICINAL CHEMISTRY, 2003, 46 (22) : 4648 - 4656
  • [3] Picolinic acids as β-exosite inhibitors of botulinum neurotoxin A light chain
    Bremer, Paul T.
    Xue, Song
    Janda, Kim D.
    CHEMICAL COMMUNICATIONS, 2016, 52 (84) : 12521 - 12524
  • [4] Identification of Clinically Viable Quinolinol Inhibitors of Botulinum Neurotoxin A Light Chain
    Caglic, Dejan
    Krutein, Michelle C.
    Bompiani, Kristin M.
    Barlow, Deborah J.
    Benoni, Galit
    Pelletier, Jeffrey C.
    Reitz, Allen B.
    Lairson, Luke L.
    Houseknecht, Karen L.
    Smith, Garry R.
    Dickerson, Tobin J.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (03) : 669 - 676
  • [5] Basic Tetrapeptides as Potent Intracellular Inhibitors of Type A Botulinum Neurotoxin Protease Activity
    Hale, Martha
    Oyler, George
    Swaminathan, Subramanyam
    Ahmed, S. Ashraf
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (03) : 1802 - 1811
  • [6] High-Throughput Multiplex Flow Cytometry Screening for Botulinum Neurotoxin Type A Light Chain Protease Inhibitors
    Saunders, Matthew J.
    Graves, Steven W.
    Sklar, Larry A.
    Oprea, Tudor I.
    Edwards, Bruce S.
    ASSAY AND DRUG DEVELOPMENT TECHNOLOGIES, 2010, 8 (01) : 37 - 46
  • [7] Synthesis/biological evaluation of hydroxamic acids and their prodrugs as inhibitors for Botulinum neurotoxin A light chain
    Seki, Hajime
    Pellett, Sabine
    Silhar, Peter
    Stowe, G. Neil
    Blanco, Beatriz
    Lardy, Matthew A.
    Johnson, Eric A.
    Janda, Kim D.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2014, 22 (03) : 1208 - 1217
  • [8] Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease
    Sukonpan, C
    Oost, T
    Goodnough, M
    Tepp, W
    Johnson, EA
    Rich, DH
    JOURNAL OF PEPTIDE RESEARCH, 2004, 63 (02): : 181 - 193
  • [9] Synthesis and activity of isoleucine sulfonamide derivatives as novel botulinum neurotoxin serotype A light chain inhibitors
    Thompson, Jordan C.
    Dao, Wendy T.
    Ku, Alex
    Rodriguez-Beltran, Sandra L.
    Amezcua, Martin
    Palomino, Alejandra Y.
    Lien, Thanh
    Salzameda, Nicholas T.
    BIOORGANIC & MEDICINAL CHEMISTRY, 2020, 28 (18)
  • [10] Thio-derived disulfides as potent inhibitors of botulinum neurotoxin type B: Implications for zinc interaction
    Anne, C
    Blommaert, A
    Turcaud, S
    Martin, AS
    Meudal, H
    Roques, BP
    BIOORGANIC & MEDICINAL CHEMISTRY, 2003, 11 (21) : 4655 - 4660
12345